Zobrazeno 1 - 10
of 216
pro vyhledávání: '"M C, Bissery"'
Autor:
M. C. Bissery
Publikováno v:
Current Pharmaceutical Design. 7:1251-1257
Paclitaxel and docetaxel are two key molecules in the treatment of a variety of cancers with major impact in the treatment of breast, lung and ovarian cancers. A number of taxoids have then been synthesized in an effort to improve some of the feature
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1b85ff271b2bda484d52b61c5340bff
https://doi.org/10.2174/1381612013397465
https://doi.org/10.2174/1381612013397465
Publikováno v:
British Journal of Cancer
We have studied the state of microtubule associated protein 2 (MAP2) in the pancreatic ductal adenocarcinomas P03 and P02 (sensitive and refractory to docetaxel respectively) since they express the corresponding mRNA and MAP2-related peptides. Immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::592a3d39ddb4c04754556f812f542313
https://doi.org/10.1054/bjoc.2000.1294
https://doi.org/10.1054/bjoc.2000.1294
Autor:
Zhou, Jiaqi1,2 (AUTHOR), Huang, Yi‐chun1 (AUTHOR), Wang, Wanlong1,2 (AUTHOR), Li, Jiawei1,2 (AUTHOR), Hou, Yibo1 (AUTHOR), Yi, Ziqi1 (AUTHOR), Yang, Haowei1,2 (AUTHOR), Hu, Keer1 (AUTHOR), Zhu, Yu1 (AUTHOR), Wang, Zitian1 (AUTHOR), Ma, Shaohua1,2,3 (AUTHOR) ma.shaohua@sz.tsinghua.edu.cn
Publikováno v:
Advanced Science. 7/24/2024, Vol. 11 Issue 28, p1-13. 13p.
Autor:
François Lavelle, M.‐C. Bissery, Suzy Cros, J. Renault, Michel Baron, Sylviane Giorgi-Renault, Patricia Gebel-Servolles, Ghanem Atassi, C. Paoletti
Publikováno v:
ChemInform. 22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad64fdd905487416879ce94f00aab875
https://doi.org/10.1002/chin.199122166
https://doi.org/10.1002/chin.199122166
Publikováno v:
Pathologie-biologie. 51(4)
We previously demonstrated a circadian rhythm in response to docetaxel chemotherapy in C3H/HeN mice bearing MA13/C mammary adenocarcinoma. We investigated the relation between this rhythm and the expression of BCL-2 in bone marrow and in tumor tissue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3b75f4b30c723e035b1c9ea2fd1d3f06
https://pubmed.ncbi.nlm.nih.gov/12852995
https://pubmed.ncbi.nlm.nih.gov/12852995
Autor:
Mario Campone, P. Fumoleau, M.-C. Bissery, Geneviève Perrocheau, N. Azli, Valérie Delecroix, A. Riva, J. P. Louboutin, R. Deporte-Fety, L. Vernillet, O. Borg-Olivier
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 12(7)
Summary Background and purpose: Anthracycline-containing regimens are widely used in advanced breast cancer. However, there is a need for new, non-anthracycline regimens that are active in patients for whom anthracyclines are contraindicated. The aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::727d5468cd7f773f1645851e3cdf2dbd
https://pubmed.ncbi.nlm.nih.gov/11521794
https://pubmed.ncbi.nlm.nih.gov/11521794
Tau expression in model adenocarcinomas correlates with docetaxel sensitivity in tumour-bearing mice
Publikováno v:
British Journal of Cancer
Docetaxel is a new taxoid with clinical activity in breast and lung cancer. Using docetaxel-sensitive and -refractory mammary and pancreatic murine tumours, as well as human-derived neoplasms, we investigated if a determinant of docetaxel sensitivity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b609658366ad8af3bc5dab10d9dfc40d
https://pubmed.ncbi.nlm.nih.gov/9764577
https://pubmed.ncbi.nlm.nih.gov/9764577
Publikováno v:
Seminars in oncology. 23(1 Suppl 3)
CPT-11 (irinotecan) is a water-soluble analogue of camptothecin (CPT), an antitumor drug extracted from the Chinese tree Camptotheca acuminata. SN-38 is an active metabolite of CPT-11 that contributes significantly to its activity. The antitumor effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4400f4d9155b4c4c450df4ab151ba1d5
https://pubmed.ncbi.nlm.nih.gov/8633248
https://pubmed.ncbi.nlm.nih.gov/8633248
Publikováno v:
Seminars in oncology. 22(6 Suppl 13)
Docetaxel (Taxotere; Rhône-Poulenc Rorer, Antony, France) is a new taxoid currently being studied in phase II and III clinical trials worldwide, with promising activity in breast cancer. Docetaxel was evaluated as a single agent against against seve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::478e481594f81394ab00a0a79722d48d
https://pubmed.ncbi.nlm.nih.gov/8604451
https://pubmed.ncbi.nlm.nih.gov/8604451
Publikováno v:
Anti-cancer drug design. 10(4)
In order to study the structure-activity relationships in the series of new intercalating polycyclic agents, 1-amino-substituted pyrido[3,4-b]quinoxalines, benzo[f]pyrido[4,3-b]quinoxaline derivatives bearing a dibasic side chain and their benzo[f]py
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::281345fa1ad307849887c6460c1b887c
https://pubmed.ncbi.nlm.nih.gov/7786395
https://pubmed.ncbi.nlm.nih.gov/7786395